世俱杯2025赛程_中国足彩网首页官网_埃弗顿vs托特纳姆热刺_中国女排现状 - 奥运女足历届冠军一览表

  • 13585831301
  • 021-59541103 021-60443211
  • 3004967995

KU 59403

  • 產品貨號:CS-01Y70386
  • 產品價格:電議
  • 產品產地:進口、國產
  • 包裝類型:250mg 500mg
  • 采購熱度:216
  • 庫存:100
  • CAS號:845932-30-1
  • 方法:
  • 含量:>98.00%
  • 品牌名稱:莼試
  • 分子式:C29H32N4O4S2
  • 分子量:564.72

簡介內容:質量保證、價格優惠

在線訂購  免費訂購熱線:021-59541103 021-60443211

標簽:KU 59403 

產品目錄

聯系我們

聯系人:高小姐

電話:021-59541103 021-60443211

手機:13585831301

Q Q: 3004967995

Email:3004967995@qq.com

詳細地址:上海嘉定區嘉羅公路1661

商品詳情購物流程代測服務付款方式常見問題

化學性質:                                                                                                             

規格

250mg 500mg

CAS

845932-30-1

別名

N/A

化學名

N/A

分子式

C29H32N4O4S2

分子量

564.72

溶解度

Soluble in DMSO

儲存條件

Store at -20°C

General tips

For obtaining a higher solubility , please warm the tube at 37 and shake it in the ultrasonic bath for a while.

Shipping Condition

Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request

 

產品描述:                                                                                                            

KU 59403 is a potent ATM inhibitor, with an IC50 of 3 nM.

KU 59403 is a novel ATM inhibitor developed from LY294002, which is more potent against ATM than the previous lead KU 55933 (IC50=3 nM vs 13 nM), and has at least 1000 times greater specificity for ATM over other members of the PI3K family tested. KU 59403 is an effective chemosensitiser at a concentration of 1 μM. KU 59403 alone is not significantly cytotoxic to LoVo or SW620 cells (88±7% and 91±6% survival, respectively) but it enhances camptothecin cytotoxicity in both cell lines with greater enhancement being observed in the LoVo compared to the SW620 cells. KU 59403 also significantly enhances the cytotoxicity of fixed concentrations of etoposide (0.1 and 1 μM) or doxorubicin (10 or 100 nM) in these cell lines, with greater enhancement of etoposide in SW620 cells and of doxorubicin in LoVo cells. KU 59403 (1 μM) enhances etoposide (1 μM) cytotoxicity to a similar extent in HCT116 and HCT116-N7 cells, and in the p53 mutant SW620 cells and human breast cancer cell line, MDAMB-231, sensitisation is 11.9±4.7 and 3.8±1.8-fold respectively. Inhibition of IR-induced ATM activity by KU 59403 (1 μM) is approximately 50% in MDA-MB231 cells and >50% in HCT116 cells that have low ATM expression and activity[1].

Tumours in control mice reach 4 times their starting volume (RTV4) at a median time of 6.5 days. Treatment with etopophos alone causes a modest tumour growth delay of 4 days (time to RTV4=10.5 days). This delay is extended to 8.5 days when given with KU 59403 at 12.5 mg/kg i.p. twice daily for 5 days and 11.5 days (time to RTV4=18 days) when given with KU 59403 at 25 mg/kg i.p. twice daily for 5 days. This latter treatment is the most effective dosing schedule for KU 59403 identified; increasing etopophos efficacy by 190%. In contrast, when KU59403 is administered 4 hours after etopophos administration there is no increase in efficacy compared with etopophos alone. In the above studies, neither KU 59403 nor etopophos given as a single agent caused any measurable toxicity and the combination of drugs did not cause unacceptable toxicity. However, the etopophos-induced tumour growth delay is extended to 8.5 days by co-administration of KU 59403, representing a 300% enhancement of etopophos activity that was statistically significant. Toxicity, as measured by body weight loss, is tolerable and transient. In this study irinotecan alone causes an initial modest regression of the SW620 tumour followed by rapid re-growth resulting in a tumour growth delay of 7.5 days, which is extended to 19.5 days by the co-administration of KU 59403. As is clearly indicated from these data, enhancement of the efficacy of etopophos can be obtained in the SW620 and HCT116 xenograft models, and of irinotecan in the SW620 model, by combination with KU 59403 with little enhancement of toxicity[1].

特別提醒:                                                                                                              

1. 本產品僅供科研使用。請勿用于醫藥、臨床診斷或治療,食品及化妝品等用途。請勿存放于普通住宅區。

2. 為了您的安全和健康,請穿好實驗服并佩戴一次性手套和口罩操作。

原創作者:上海莼試生物技術有限公司

在線咨詢

留言注意事項:

1.遵守中華人民共和國有關法律、法規,尊重網上道德,承擔一切因您的行為而直接或間接引起的法律責任。

2.請您真實的反映產品的情況,不要捏造、誣蔑、造謠。如對產品有任何疑問,也可以留言咨詢。

3.未經本站同意,任何人不得利用本留言簿發布個人或團體的具有廣告性質的信息或類似言論。

    您感興趣的產品*
    您的單位*
    聯系人*
    聯系電話*
    詳細地址*
    常用郵箱*
    請輸入您對我們的意見或建議*
    驗證碼*

同類產品

訂購流程

訂貨流程

產品訂購說明:

  

1、報價含普票、運費。

2、常用試劑備貨充足,除對溫度要求極其嚴格的產品當天可發貨。

  

3、進口原裝產品要3-6周的貨期,詳細情況請咨詢客服。

  

4、訂貨時間為工作日每周一至周五16:00之前。

  

5、如需代為檢測,標本對環境溫度高,可聯系客服安排專人取樣(限省內客戶)。

  

6、代測免收代測費,一周出結果。

7、產品因運輸途中包裝破損請拒絕簽收,做退回。我們將在24小時之內為您補發 損壞產品。

8、如因單位財務制度原因,可申請先發貨,報賬后付款(此條款僅限醫院、學校信譽良好客戶)。

付款方式

普票匯款信息

  

賬 戶 名:上海生物

開 戶 行:中國銀行山東省分行營業部

  

賬 號:2169 2341 6278

 為方便廣大客戶辦理貨款我公司提供多個銀行的賬戶,學校、醫院客戶購買產品如因單位財務制度原因可先發貨待報賬后匯款,請及時告知銷售人員已做具體操作。